Workflow
If You Invested $10K In Essex Property Stock 10 Years Ago, How Much Would You Have Now?
Yahoo Finance· 2025-09-15 12:00
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Essex Property Trust Inc. (NYSE:ESS) is a real estate investment trust that acquires, develops, redevelops, and manages apartment communities located in supply-constrained markets. It is set to report its Q3 2025 earnings on Oct. 28. Wall Street analysts expect the company to post EPS of $2.68, down from $3.91 in the prior-year period. According to Benzinga Pro, quarterly revenue is expected to reach $472. ...
ULTY: Strategy Has Improved, But Let's Maintain Realistic Expectations
Seeking Alpha· 2025-09-15 12:00
YieldMax Ultra Option Income Strategy ETF (NYSEARCA: ULTY ) has grown to be one of the most popular weekly-paying option ETFs. This can likely be attributed to the high starting dividend yield that currently sitsFinancial analyst by day and a seasoned investor by passion, I've been involved in the world of investing for over 15 years and honed my skills in analyzing lucrative opportunities within the market.I specialize in uncovering high quality dividend stocks and other assets that offer potential for lon ...
Analysts Predict 4 S&P 500 Stocks Will Outgrow Nvidia And Palantir
Investors· 2025-09-15 12:00
BREAKING: Futures Rise As Tesla Soars On Elon Musk Share Buy Investors are understandably excited about the revenue growth prospects at Nvidia (NVDA) and Palantir (PLTR). But some S&P 500 stocks' growth looks even stronger this year. Analysts predict the revenue of four S&P 500 stocks, including Expand Energy (EXE), TKO Group (TKO), EQT (EQT) and KeyCorp (KEY), will jump by 60% or more this calendar year, says an Investor's Business Daily analysis of data from S&P Global Market Intelligence and MarketSurge. ...
California Resources Corporation Announces All-Stock Combination with Berry Corporation
Globenewswire· 2025-09-15 12:00
Highly Accretive Transaction Across Key Financial Metrics Enhances CRC’s Portfolio Combination to Create a Stronger, More Efficient Leader in California Energy LONG BEACH, Calif. and DALLAS, Sept. 15, 2025 (GLOBE NEWSWIRE) -- California Resources Corporation (NYSE: CRC) (“CRC”) and Berry Corporation (NASDAQ: BRY) (“Berry”) jointly announced today their entry into a definitive agreement to combine in an all-stock transaction valuing Berry at approximately $717 million, inclusive of Berry’s net debt1. Under t ...
Arbe Tier-1 Sensrad Secures an Order from WATCHIT for Boat Collision Prevention
Prnewswire· 2025-09-15 12:00
Accessibility StatementSkip Navigation Sensrad's Hugin D1 radar, powered by Arbe's chipset, selected to deliver a first-of-its-kind safety and perception solution for recreational boats Arbe (Nasdaq: ARBE), a global leader in ultra-high-resolution radar solutions, is driving a radar revolution. Its cutting-edge radar chipset delivers up to 100 times more detail than other radar systems, empowering automakers and radar Tier-1s to develop truly safe driving systems that scale from ADAS to hands-free, eyes- of ...
International Land Alliance Launches BOXABL at Cabo Oasis
Globenewswire· 2025-09-15 12:00
Affordable Tesla-Powered BOXABL Tiny Homes Coming to Cabo Oasis Expanding Flagship Development SAN DIEGO, Sept. 15, 2025 (GLOBE NEWSWIRE) -- International Land Alliance, Inc. (OTCQB: ILAL) (“ILAL” or the “Company”), a global real estate investment and development firm, today announced that the wildly-popular tiny home brand, BOXABL, is now available for ordering at its flagship 500-acre Cabo Oasis beachfront development in Baja California. The Company expects the BOXABL model home, which is now a part of it ...
NETCLASS TECHNOLOGY INC Announces $2.4 Million Private Placement (PIPE) Financing to Advance AI Applications and Blockchain Initiatives in Singapore
Globenewswire· 2025-09-15 12:00
SINGAPORE and HONG KONG, Sept. 15, 2025 (GLOBE NEWSWIRE) -- NETCLASS Technology INC (Nasdaq: NTCL; the “Company” or “NetClass”), a leading B2B smart education IT solutions provider with offices in Shanghai, Hong Kong, Singapore and Tokyo, today announced that on August 31, 2025, the Company entered into a securities purchase agreement (the “Agreement”) with an institutional investor (the “Investor”) relating to a private placement of 1,500,000 Class A ordinary shares at $1.60 per share, for gross proceeds o ...
Genius Group executes buyback of one million shares, increases company shares in book entry to 60.3%
Globenewswire· 2025-09-15 12:00
SINGAPORE, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group, today announced that the Company bought back one million shares of its stock on the open market at an average price of $0.90 per share, in the period from August 28 to September 11, 2025. The buyback is the third buyback the Company has executed further to receiving shareholder and board approval for a share buyback of up to 20% of th ...
DiamondLake Withdraws from Unicoin Transaction, Reaffirms Commitment to SEC Compliance and Tokenization Strategy
Globenewswire· 2025-09-15 12:00
SALT LAKE CITY, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Diamond Lake Minerals, Inc. (OTC: DLMI) based upon our findings during due diligence DiamondLake is withdrawing from the Unicoin transaction and terminating the Memorandum of Understanding. DiamondLake has attempted in good faith to pursue the Share Exchange with Unicoin however it was simply not possible based upon our findings. Thus, The Board of DiamondLake feels that it is in our shareholders best interest not to further pursue this transaction. “Based ...
Spyre Therapeutics Doses First Patient in Pioneering Phase 2 SKYWAY Basket Trial of SPY072, the First Anti-TL1A Antibody Studied in Rheumatic Diseases
Globenewswire· 2025-09-15 12:00
SPY072 is a potential first- and best-in-class anti-TL1A antibody for rheumatic diseases targeting quarterly or twice-yearly subcutaneous dosing SKYWAY study is evaluating SPY072 in patients with moderate-to-severely active rheumatoid arthritis (RA), psoriatic arthritis (PsA), and axial spondyloarthritis (axSpA) Proof-of-concept data for all three indications are expected in 2026 SKYLINE and SKYWAY trials are expected to provide 9 proof-of-concept readouts in 2026-27 WALTHAM, Mass., Sept. 15, 2025 (GLOBE NE ...